This provider's $24.8M in total Medicare payments ranks in the 96th percentile of Clinical Laboratory providers nationally.
Their average markup ratio of 5.16x is significantly above the specialty median of 3.7x.
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2021 | $1.8K | $348.06 | 5.16x | $1.4K | $20.4M | 27.9K | 27.9K |
| 2022 | $2.4K | $491.09 | 4.92x | $1.9K | $4.4M | 7.0K | 6.9K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 81442 | Gene analysis (noonan syndrome) genomic sequence analysis | 3.0K | $6.5M | $2.1K | 5.18x |
| 81408 | Molecular pathology procedure level 9 | 2.0K | $4.0M | $2.0K | 5.17x |
| 81411 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel | 2.9K | $3.9M | $1.3K | 5.10x |
| 81407 | Molecular pathology procedure level 8 | 2.0K | $1.7M | $846.27 | 5.17x |
| 81414 | Test for detecting genes associated with heart disease, duplication/deletion analysis panel, at least 2 genes | 2.9K | $1.7M | $584.82 | 5.35x |
| 81413 | Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 10 genes | 2.9K | $1.7M | $584.82 | 5.17x |
| 81410 | Test for detecting genes associated with heart disease, genomic sequence analysis panel, at least 9 genes | 3.1K | $1.5M | $503.45 | 5.18x |
| 81405 | Molecular pathology procedure level 6 | 3.2K | $962.8K | $301.35 | 5.17x |
| 81404 | Molecular pathology procedure level 5 | 3.2K | $879.2K | $274.83 | 5.17x |
| 81403 | Molecular pathology procedure level 4 | 3.2K | $591.5K | $185.20 | 5.17x |
| 81406 | Molecular pathology procedure level 7 | 2.0K | $563.2K | $282.88 | 5.17x |
| 81401 | Molecular pathology procedure level 2 | 3.3K | $447.3K | $137.00 | 5.17x |
| 81238 | Gene analysis (coagulation factor ix) full sequence analysis | 277 | $165.5K | $597.38 | 2.43x |
| 81307 | Gene analysis (partner and localizer of brca2) full sequence analysis | 52 | $34.8K | $669.99 | 5.14x |
| 81226 | Gene analysis (cytochrome p450, family 2, subfamily d, polypeptide 6) common variants | 73 | $32.7K | $448.01 | 5.20x |
| 81317 | Gene analysis (postmeiotic segregation increased 2 [s cerevisiae]) full sequence analysis | 41 | $27.4K | $669.07 | 5.12x |
| 81435 | Test for detecting genes associated with colon cancer, genomic sequence analysis panel, at least 10 genes | 33 | $19.1K | $578.87 | 5.22x |
| 81291 | Gene analysis (5, 10-methylenetetrahydrofolate reductase) common variants | 201 | $13.1K | $65.01 | 5.20x |
| 81225 | Gene analysis (cytochrome p450, family 2, subfamily c, polypeptide 19) common variants | 45 | $13.0K | $289.61 | 5.20x |
| 81249 | Gene analysis (glucose-6-phosphate dehydrogenase) full sequence analysis | 19 | $11.3K | $594.00 | 3.44x |
This provider submits charges 5.16 times higher than what Medicare actually pays.
A markup ratio of 5.16x means for every $100 Medicare pays, this provider initially charges $516. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Other Clinical Laboratory providers in TX for peer comparison.
| Provider | Location | Total Payments | Status |
|---|---|---|---|
| Clinical Pathology Laboratories, Inc. | Austin, TX | $541.0M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Irving, TX | $453.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Dallas, TX | $389.6M | ⚠️ Flagged |
| Quest Diagnostics Clinical Laboratories Inc | Houston, TX | $311.2M | ⚠️ Flagged |
| Laboratory Corporation Of America | Houston, TX | $299.4M | ⚠️ Flagged |
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data